Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock waves or sugar water? new study tests two tennis elbow treatments

NCT ID NCT07620678

Symptom relief Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two treatments for tennis elbow (lateral epicondylitis): shock wave therapy and a single injection of 5% dextrose (sugar water). 96 adults with persistent pain for at least 3 months were split into three groups: standard care alone, standard care plus shock waves, or standard care plus the injection. Researchers measured pain, grip strength, and function over time to see which approach worked better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
5% dextrose injection
What this could lead to
If one treatment proves superior, it could offer a more effective, non-surgical option for tennis elbow pain relief.
What could go wrong
This is a small, completed trial comparing two existing treatments. Neither may be clearly better than the other, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

96 people

The number who actually took part.

Started

Oct 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-75 years * Clinical and ultrasonographic diagnosis of lateral epicondylitis * Symptoms persisting for at least 3 months * Visual Analog Scale (VAS) score ≥4 * Resistance to previous medical treatment * Ability to comply with study procedures and complete questionnaires Exclusion Criteria: * Injection treatment for lateral epicondylitis within the previous 3 months * History of trauma within the previous 3 months * Cervical disc herniation * Median or ulnar tunnel neuropathy * Medial epicondylitis * Anticoagulant therapy use * Pregnancy or breastfeeding * Psychiatric disorders or cognitive impairment interfering with questionnaire -completion * Allergy to the treatment solution * History of upper extremity surgery or fracture * Rheumatoid arthritis * Connective tissue diseases such as dermatomyositis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lateral epicondylitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epicondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lateral epicondylitis Lateral epicondylitis (tennis elbow)

Contacts and locations

Locations

  • SBU Ankara Physical Medicine and Rehabilitation Training and Research Hospital Ankara, Turkey

    Ankara, Cankaya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.